Molecular subtyping reveals immune alterations in IDH wild‐type lower‐grade diffuse glioma-Reference-Cited by-同舟云学术

Molecular subtyping reveals immune alterations in IDH wild‐type lower‐grade diffuse glioma

Published:2020-06-15 Issue:3 Volume:251 Page:272-283
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Wu Fan¹²³,Li Guan‐Zhang¹²,Liu Han‐Jie¹²,Zhao Zheng¹²³,Chai Rui‐Chao¹²³,Liu Yu‐Qing¹²³,Jiang Hao‐Yu¹²,Zhai You¹²,Feng Yue‐Mei¹²,Li Ren‐Peng¹²,Zhang Wei¹²³^ORCID

Affiliation:

1. Department of Molecular Neuropathology, Beijing Neurosurgical Institute Capital Medical University Beijing PR China

2. Department of Neurosurgery, Beijing Tiantan Hospital Capital Medical University Beijing PR China

3. Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA) Beijing PR China

Funder

National Natural Science Foundation of China

Research and Development

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5468

Reference53 articles.

1. Primary brain tumours in adults

2. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

3. CGCG clinical practice guidelines for the management of adult diffuse gliomas

4. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

5. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases;Heliyon;2024-08

2. The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis;Human Genomics;2024-07-02

3. A robust primary liver cancer subtype related to prognosis and drug response based on a multiple combined classifying strategy;Heliyon;2024-02

4. WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy;European Journal of Medical Research;2024-01-03

5. Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome;American Journal of Cancer Research;2024